DotLab

DotLab is a personalized pharmaceutical company specifically targeting women's health. It has developed the world's first non-invasive test for endometriosis, a chronic condition affecting one in ten women globally and the leading cause of unexplained infertility. The company has been recognized by Goldman Sachs’ entrepreneurship initiative, the World Health and Medical Technology Network, Forbes as one of the top ten tech startups founded by women, and MIT Technology Review’s watchlist for emerging technologies.